130 related articles for article (PubMed ID: 12893422)
1. The temporal localization of frame-shift ubiquitin-B and amyloid precursor protein, and complement proteins in the brain of non-demented control patients with increasing Alzheimer's disease pathology.
Konishi Y; Beach T; Sue LI; Hampel H; Lindholm K; Shen Y
Neurosci Lett; 2003 Sep; 348(1):46-50. PubMed ID: 12893422
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging.
Maarouf CL; Daugs ID; Kokjohn TA; Walker DG; Hunter JM; Kruchowsky JC; Woltjer R; Kaye J; Castaño EM; Sabbagh MN; Beach TG; Roher AE
PLoS One; 2011; 6(11):e27291. PubMed ID: 22087282
[TBL] [Abstract][Full Text] [Related]
3. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
[TBL] [Abstract][Full Text] [Related]
4. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
[TBL] [Abstract][Full Text] [Related]
5. Neurofibrillary tangles of Guam parkinson-dementia are associated with reactive microglia and complement proteins.
Schwab C; Steele JC; McGeer PL
Brain Res; 1996 Jan; 707(2):196-205. PubMed ID: 8919296
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
7. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
8. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
9. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
12. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
Asai M; Kawakubo T; Mori R; Iwata N
Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer disease pathology in amyotrophic lateral sclerosis.
Hamilton RL; Bowser R
Acta Neuropathol; 2004 Jun; 107(6):515-22. PubMed ID: 15024584
[TBL] [Abstract][Full Text] [Related]
14. Amyloid, dementia and Alzheimer's disease.
Hyman BT; Tanzi RE
Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):88-93. PubMed ID: 1623244
[TBL] [Abstract][Full Text] [Related]
15. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
16. A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type.
McKenzie JE; Edwards RJ; Gentleman SM; Ince PG; Perry RH; Royston MC; Roberts GW
Acta Neuropathol; 1996; 91(5):526-9. PubMed ID: 8740234
[TBL] [Abstract][Full Text] [Related]
17. The cellular pathology associated with Alzheimer beta-amyloid deposits in non-demented aged individuals.
Coria F; Moreno A; Rubio I; García MA; Morato E; Mayor F
Neuropathol Appl Neurobiol; 1993 Jun; 19(3):261-8. PubMed ID: 8355812
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
Nguyen TV; Hayes M; Zbesko JC; Frye JB; Congrove NR; Belichenko NP; McKay BS; Longo FM; Doyle KP
Acta Neuropathol Commun; 2018 Sep; 6(1):100. PubMed ID: 30249297
[TBL] [Abstract][Full Text] [Related]
19. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
20. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
Thal DR; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
